Last reviewed · How we verify
NCT03597880
Preoperative Evaluation of Airway
NA trial testing obese patients in Obesity in 489 participants. Completed in 1 January 2018.
1 January 2018
Quick facts
| Lead sponsor | Yeditepe University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Design | sequential |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 489 |
| Start date | 1 January 2015 |
| Primary completion | 1 January 2018 |
| Estimated completion | 1 January 2018 |
Drugs / interventions tested
- obese patients
Conditions studied
- Obesity — all drugs for Obesity →
- Difficult Intubation — all drugs for Difficult Intubation →
Sponsor
Yeditepe University Hospital
Who can join
Adults 18 to 65, any sex, with Obesity or Difficult Intubation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluation of airway markers of patients who have undergone obesity surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03597880
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of obese patients
Trials testing the same drug.
- NCT05391958 — Pharmacodynamics of Injection of Cisatracurium Base on Lean Body Mass Pattern to Maintain Deep Neuromuscular Blockade in · NA · completed
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Yeditepe University Hospital trials
Trials by the same sponsor.
- NCT06719726 — PECS I Block vs. Local Infiltration in Breast Augmentation Pain Management · NA · completed
- NCT06539273 — Exosome Treatment in Androgenetic Alopecia · Phase 3 · completed
- NCT04070014 — Relationship Between Heme Oxygenase 1 Enzyme Level and Coronary SYNTAX Score · completed
- NCT03355807 — Use of MgSO4 for Pain After Bariatric Surgery · NA · completed
- NCT03482492 — Tramadol vs.Tramadol With Paracetamol · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03597880 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yeditepe University Hospital
- Last refreshed: 24 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03597880.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing